国泰海通创新医药混合发起C(021987)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2026-03-30 |
58,530,631.40 |
19,103,225.50 |
10,698,918.94 |
50,126,324.84 |
| 2025-12-30 |
42,418,173.18 |
58,530,631.40 |
45,639,646.15 |
29,527,187.93 |
| 2025-09-29 |
50,522,508.53 |
42,418,173.18 |
5,012,707.75 |
13,117,043.10 |
| 2025-06-29 |
61,348,981.68 |
50,522,508.53 |
6,656,280.77 |
17,482,753.92 |
| 2025-03-30 |
129,409,667.13 |
61,348,981.68 |
4,368,640.04 |
72,429,325.49 |
| 2024-12-30 |
21,594,376.00 |
129,409,667.13 |
130,264,959.92 |
22,449,668.79 |
| 2024-09-29 |
- |
21,594,376.00 |
21,701,273.74 |
106,897.74 |
微信公众号
证券之星APP
基本资料
